- Sort by Popularity (sales)
- Display 15 Products per page
Medical Device Tax: Will There Be a R&D Effect?
Published: September 13, 2013 | Price: $50.00 – $100.00
The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information. While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program. The conclusions are the result of information from Kalorama Information's...
The IVD Market in Brazil
Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...
The World Market for Cloud Computing in Healthcare (Saas, IaaS, PaaS, Other Cloud Markets, Healthcare IT Spending and Other Trends)
Published: September 10, 2013 | Price: $995.00 – $1,990.00
The World Market for Cloud Computing in Healthcare Healthcare providers around the world are facing rising costs while they attempt to maintain or improve care. Healthcare information technology (HIT) is a key component of streamlining healthcare in a way that can provide benefits to those involved. As this report details, cloud computing is a way of using existing technology to modernize the healthcare industry. Cloud technologies are generally off-site, third-party-managed computing resources that can include computational resources, additional data storage...
The World Market for Minimally Invasive Surgical Devices (Cardiovascular, ENT, Neurosurgery, Gastrointestinal, Urological/Gynecological and Other MIS Device Markets)
Published: August 21, 2013 | Price: $2,500.00 – $5,000.00
This report, The World Market for Minimally Invasive Surgical Devices, includes product information, procedure volume data, world demographics, and other general issues affecting the MIS device market. Minimally invasive surgery (MIS) currently allows doctors to perform many complicated operations with a short hospital stay, better patient satisfaction and outcomes. The concept has driven the growth of devices for minimally invasive procedures. In this report, a detailed market analysis includes six general surgery areas reflecting revenues earned by all manufacturers in...
The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry
Published: August 16, 2013 | Price: $995.00 – $1,995.00
The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry The "Patient Protection and Affordable Care Act" (H.R. 3590) is complex legislation that affects virtually every aspect of health care, and many of its provisions are beginning to take effect now. IVD manufacturers who have different needs and strategies are now considering the legislation and whether it will help or hurt business plans. The legislation contains a range of different provisions and while the law in a broad sense...
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)
Published: August 9, 2013 | Price: $3,995.00 – $7,990.00
This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. ...
IVD in Australia
Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...
IVD in China
Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends)
Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...
The Market for Tablet PCs In Healthcare (Markets and Usage in Hospitals, Physician Offices, Nursing Homes and Other Settings)
Published: June 25, 2013 | Price: $1,500.00 – $3,000.00
The growing demands on the health industry have resulted in higher demand for new and better medical technology products. New technologies in the health IT segment are emerging in response to increased healthcare needs of an aging population, streamlining and efficiency demands, changes in reimbursement, new wireless technologies including wireless monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. In particular, the Tablet PC has been focused on as it mimics clipboards and other products...
The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)
Published: June 25, 2013 | Price: $3,995.00 – $7,990.00
This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include: Electrocardiography including ECG testing, stress testing, Holter monitoring, event monitoring and implantable loop. Cardiac imaging including non-invasive X-Ray, MRI, CT, ultrasound, and nuclear cardiography; and invasive /cardiac catheterization/angiography, intravascular ultrasound, optical coherence technology and electrophysiology. Cardiac point-of-care including cholesterol testing and coagulation testing Cardiac markers Cardiac contrast agents...
Out of Pocket Healthcare Spending 2013
Published: June 18, 2013 | Price: $1,500.00 – $3,000.00
This report, Out of Pocket Healthcare 2013, is Kalorama's latest estimates for the amount spent by consumers on their own (through cash payments, credit cards, FSAs and finance programs) for healthcare services. The out-of -pocket market for the following areas are included: Doctors Pharmaceuticals Hospitals ER Vision Dental Elective Procedures The report estimates the amount spent in cash/checks and the amount financed. As part of the report, spending for the following healthcare costs are provided for years 2008-2016: Premiums Co...
The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs)
Published: June 13, 2013 | Price: $2,500.00 – $5,000.00
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S., Europe, Japan and globally. With over 400 pages of market analysis and over 120 figures and tables, the report provides in-depth coverage of key competitors and important trends and challenges for makers of orphan drug treatments. Osteoporosis,...